Red Lettuce Polyphenol Production via Phenylpropanoid Pathway Regulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need to increase the levels of health-beneficial polyphenols in the human diet, particularly in blueberries, which are underconsumed and high in sugar, while also developing alternative plants with higher polyphenol content and lower sugar content to promote health and commercial viability.
Innovation Solution
The development of red lettuces with enhanced polyphenol production using plant eustressors/elicitors and regulation of the phenylpropanoid pathway to stimulate secondary metabolite production, along with the creation of expression cassettes for heterologous polynucleotides that increase polyphenol production, resulting in increased levels of quercetin derivatives, chicoric acid, and chlorogenic acids.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If blueberries are consumed to increase polyphenol intake, then health benefits are improved, but sugar consumption increases and cost-effectiveness decreases
Solution Approach 1:
The patent changes the source parameter from blueberries to red lettuce, fundamentally altering the food matrix while maintaining high polyphenol content. This substitution allows achieving the same health benefit (increased polyphenol intake) without the harmful side effect (high sugar content), as red lettuce naturally contains minimal sugar compared to blueberries
2Quantity of substance
If conventional breeding is used to increase polyphenol content in lettuce, then health benefits are improved, but breeding time and complexity increase
Solution Approach 1:
The patent applies preliminary action by pre-identifying and selecting specific genetic markers (SNPs) associated with high polyphenol production in red lettuce varieties. This preliminary genetic characterization allows for rapid selection and breeding of high-polyphenol lettuce lines, dramatically reducing the time required compared to conventional trial-and-error breeding approaches
Solution Approach 2:
The patent implements feedback mechanisms through molecular marker-assisted selection, where genetic markers are used to monitor and select for desired polyphenol-related traits during breeding. This feedback loop enables breeders to make informed selections based on genetic potential rather than waiting for phenotypic expression, accelerating the breeding process while ensuring high polyphenol content in the final variety
3Quantity of substance
If genetic modification is used to enhance polyphenol production, then polyphenol content is improved, but regulatory approval and public acceptance become more difficult
Solution Approach 1:
The patent employs self-service by utilizing naturally occurring genetic variations (SNPs) already present in red lettuce populations to enhance polyphenol production. This approach leverages the plant's own genetic diversity rather than introducing foreign genes, allowing the lettuce to self-regulate polyphenol biosynthesis through its endogenous metabolic pathways. This eliminates the need for complex GMO regulatory approvals while achieving the desired increase in polyphenol content
4Quantity of substance
If high-polyphenol red lettuce is developed through traditional breeding, then health benefits are improved, but production cost and scalability decrease
Solution Approach 1:
The patent performs preliminary action by conducting comprehensive genomic analysis and SNP identification in red lettuce populations before breeding programs begin. This upfront investment in genetic characterization creates a robust selection framework that can be applied across large breeding populations, enabling scalable production of high-polyphenol lettuce varieties without proportionally increasing costs as production scales up
Data Source
AI summary
Provided herein are systems and methods for enhancement of polyphenols, such as chlorogenic acids, chicoric acid, anthocyanins, and water-soluble quercetin derivatives, production in red lettuces. Also provided are transgenic lettuce for the production of polyphenols. Also provided are parts of such transgenic lettuces, such as seeds leaves, and extracts. The disclosure also provides methods of using the new lettuces and parts thereof for protection against viral/bacterial infection (i.e., by inhibiting activities of COVID-19 virus/enzymes) diabetes, cardiovascular diseases, memory and eyesight loss, inflammation, and cancer.